ADAM-mediated Shedding in Inflammatory Responses Inflammation is a key process in disease pathogenesis, and leukocyte recruitment and transendothelial migration into inflamed tissues control both initiation and progression of acute and chronic inflammatory diseases. Studies funded by this R01 have demonstrated that proteolysis mediated by two transmembrane proteases, Adam10 and Adam17, controls the inflammatory response. Our data specifically implicate (i) monocyte Adam10 in limiting monocyte emigration into inflamed vessels in vivo;(ii) neutrophil Adam17 in limiting early neutrophil influx into inflammatory sites in vivo through its cleavage of L-selectin;(iii) monocyt Adam17 in promoting monocyte diapedesis between endothelial cells in vitro, and (iv) macrophage Adam17 in promoting the resolution of inflammation. Our overall hypothesis is that cell-, substrate-, and contect-specific cleavage of key inflammatory proteins by Adam10 and Adam17 is critical to regulation of inflammatory responses. The proposed studies will build upon these observations by determining: 1) the in vitro and in vivo mechanisms by which the transmembrane proteases Adam10 and Adam17 modulate inflammatory responses;and 2) establish substrates of Adam10 and Adam17 responsible for regulation monocyte trafficking into and out of inflammatory sites. These studies have the potential to identify biomarkers to recognize patients at risk with chronic inflammatory diseases, and to help determine therapeutic strategies for their treatment.
Limited and specific proteolysis of monocyte and endothelial cell surface proteins represents a rapidly mobilized regulatory mechanism to control the inflammatory response. The proposed studies will determine mechanisms through which two transmembrane enzymes, Adam10 and Adam17, regulate transendothelial cell migration in vitro and in vivo. This research has the potential to identify biomarkers to recognize patients at risk with chronic inflammatory diseases, and to help determine therapeutic strategies for their treatment.
|Tsubota, Yoshiaki; Frey, Jeremy M; Raines, Elaine W (2014) Novel ex vivo culture method for human monocytes uses shear flow to prevent total loss of transendothelial diapedesis function. J Leukoc Biol 95:191-5|
|Nishizawa, Tomohiro; Kanter, Jenny E; Kramer, Farah et al. (2014) Testing the role of myeloid cell glucose flux in inflammation and atherosclerosis. Cell Rep 7:356-65|
|Tsubota, Yoshiaki; Frey, Jeremy M; Tai, Phillip W L et al. (2013) Monocyte ADAM17 promotes diapedesis during transendothelial migration: identification of steps and substrates targeted by metalloproteinases. J Immunol 190:4236-44|
|Yan, Fang; Liu, Liping; Dempsey, Peter J et al. (2013) A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor. J Biol Chem 288:30742-51|
|Cieslewicz, Maryelise; Tang, Jingjing; Yu, Jonathan L et al. (2013) Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival. Proc Natl Acad Sci U S A 110:15919-24|
|Wilson, Carole L; Gough, Peter J; Chang, Cindy A et al. (2013) Endothelial deletion of ADAM17 in mice results in defective remodeling of the semilunar valves and cardiac dysfunction in adults. Mech Dev 130:272-89|
|Gomez, Ivan G; Tang, Jingjing; Wilson, Carole L et al. (2012) Metalloproteinase-mediated Shedding of Integrin ?2 promotes macrophage efflux from inflammatory sites. J Biol Chem 287:4581-9|
|Tang, Jingjing; Zarbock, Alexander; Gomez, Ivan et al. (2011) Adam17-dependent shedding limits early neutrophil influx but does not alter early monocyte recruitment to inflammatory sites. Blood 118:786-94|
|Raines, Elaine W; Bornfeldt, Karin E (2010) Integrin alpha(7)beta(1) COMPels smooth muscle cells to maintain their quiescence. Circ Res 106:427-9|
|Liu, Li; Schwartz, Barbara; Tsubota, Yoshiaki et al. (2008) Cyclin-dependent kinase inhibitors block leukocyte adhesion and migration. J Immunol 180:1808-17|
Showing the most recent 10 out of 18 publications